"Based on a workshop of the Forum on Emerging Infections, Board on Global Health, Institute of Medicine." Includes bibliographical references.

The role of research in countering bioterrorism / Anthony S. Fauci -- The political perspective of the bioterrorism threat / William Frist -- Update on the implications of anthrax bioterrorism / James M. Hughes -- Framing the issues / Edward M. Eitzen, Jr. -- Framing the debate: applying the lessons learned / Michael T. Osterholm -- Building capacity to prevent and respond to bioterrorism / Margaret A. Hamburg -- Bioterrorism: communicating an effective response / Scott R. Lillibridge -- Anthrax / Arthur M. Friedlander -- Medical countermeasures against the re-emergence of smallpox virus / Peter B. Jahrling -- Tularemia and plague: assessing our understanding of the threat / David T. Dennis -- Botulinum toxin as a bioweapon / Stephen S. Arnon -- Research considerations for better understanding of biological threats / Kenneth Alibek -- Aerosol technology and biological weapons / C.J. Peters, Richard Spertzel, William Patrick. Reducing the risk: foodborne pathogen and toxin diagnostics / Susan E. Maslanka, Jeremy Sobel, Bala Swaminathan. Vaccines for threatening agents: ensuring the availability of countermeasures for bioterrorism / Philip K. Russell -- The Department of Defense and the development and procurement of vaccines against dangerous pathogens: a role in the military and civilian sector? / Anna Johnson-Winegar -- Applications of modern technology to emerging infections and disease development: a case study of ebola virus / Gary J. Nabel -- Meeting the regulatory and product development challenges for vaccines and other biologics to address terrorism / Jesse L. Goodman -- Moving the vaccine agenda forward: obstacles and opportunities / Stanley Plotkin -- Countermeasures to biological threats: the challenges of drug development / Gail H. Cassell -- The FDA and the end of antibiotics / David M. Shlaes and Robert C. Moellering, Jr. -- The role of antivirals in responding to biological threats / C.J. Peters -- New research in antitoxins / R. John Collier. Recombinant human antibody: immediate immunity from botulinum neurotoxin and other class A biothreat agents / James D. Marks -- Meeting the regulatory and product development challenges to address terrorism / Andrea Meyeroff -- Regulation and production of recombinant human antibodies / Kathryn E. Stein -- Lessons being learned: the challenges and opportunities / Julie L. Gerberding -- The response infrastructure: investigating the anthrax attacks / Bradley Perkins -- The Centers for Disease Control bioterrorism investigation / Kevin Yeskey -- VA capability to enhance the medical response to a domestic biological threat / Kristi L. Koenig -- The progress, priorities, and concerns of public health laboratories / Mary J.R. Gilchrist -- The role of the centers for public health preparedness / Stephen S. Morse -- The role of coordinated information dissemination: the cascade system in the United Kingdom / John Simpson -- State and local needs for responding to bioterrorism / Michael S. Ascher. U.S. Public Health Service Office of Emergency Preparedness / Donald C. Wetter -- Assessing state and territorial health departments / James J. Gibson -- Countering bioterrorism threats: local public health perspectives / Thomas L. Milne -- Public health priorities for responding to bioterrorism / Ruth L. Berkelman -- Innovative surveillance methods for monitoring dangerous pathogens / Julie A. Pavlin [and others] -- The use of computational modeling in responding to biological threats / Donald S. Burke -- Diagnostics and detection methods: improving rapid response capabilities / David A. Relman -- National security and openness of scientific research / Ronald M. Atlas -- Coordinating the intelligence, public health, and research communities / Craig Watz -- Virtually assured detection and response: utilizing science, technology, and policy against bioterrorism / Scott P. Layne -- Research and the public health response / Eric Eisenstadt.